Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Disease Progression × Parenteral Nutrition × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Hyperphagia 8 Malnutrition 3 Pancreatic Neoplasms 2 Neoplasms 2 Hematologic Neoplasms 2 Stomach Neoplasms 1 Postoperative Complications 1 Nasopharyngeal Carcinoma 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Hodgkin Disease 1 Hematopoietic and Lymphatic System Neoplasm 1 Head and Neck Neoplasms 1 Glucocorticoid Receptor Deficiency 1 Gastrointestinal Neoplasms 1 Disease Progression 1 Digestive System Neoplasms 1 Deglutition Disorders 1

Interventions

Lenalidomide 4 Dexamethasone 4 Cyclophosphamide 4 Bortezomib 4 Cisplatin 3 Carboplatin 3 vandetanib 2 tumor necrosis factor-alpha, CNGRC fusion protein, human 2 pomalidomide 2 pembrolizumab 2 liposomal doxorubicin 2 fludarabine 2 durvalumab 2 capivasertib 2 Radiosurgery 2 Paclitaxel 2 Nivolumab 2 Gemcitabine 2 Doxorubicin 2 Bevacizumab 2 Anthropogenic Effects 2 venetoclax 1 umbralisib 1 ublituximab 1 tremelimumab 1 tivozanib 1 ricolinostat 1 pazopanib 1 niraparib 1 nilotinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04456647 2023-08-16

PATNIC

Norwegian University of Science and Technology

Hyperphagia, Neoplasms, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡